Showing results 21 to 40 of 73
< previous
next >
Preview | Issue Date | Title | Author(s) |
| 2006 | Estrogen transactivates EGFR via the sphingosine 1-phosphate receptor Edg-3: the role of sphingosine kinase-1 | Sukocheva, O.; Wadham, C.; Holmes, A.; Albanese, N.; Verrier, E.; Feng, F.; Bernal, A.; Derian, C.; Ullrich, A.; Vadas, M.; Xia, P. |
| 2008 | Eukaryotic elongation factor 1A interacts with sphingosine kinase and directly enhances its catalytic activity | Leclercq, T.; Moretti, P.; Vadas, M.; Pitson, S. |
| 2000 | Expression of a catalytically inactive sphingosine kinase mutant blocks agonist-induced sphingosine kinase activation | Pitson, S.; Moretti, P.; Zebol, J.; Xia, P.; Gamble, J.; Vadas, M.; D'Andrea, R.; Wattenberg, B. |
| 2005 | Expression profiling reveals functionally important genes and coordinately regulated signaling pathway genes during in vitro angiogenesis | Hahn, C.; Su, Z.; Drogemuller, C.; Tsykin, A.; Waterman, S.; Brautigan, P.; Yu, S.; Kremmidiotis, G.; Gardner, A.; Solomon, P.; Goodall, G.; Vadas, M.; Gamble, J. |
| 1998 | Factors influencing the ability of HDL to inhibit the expression of vascular cell adhesion molecule-1 in endothelial cells | Ashby, D.; Rye, K.A.; Clay, M.; Vadas, M.; Gamble, J.; Barter, P. |
| 2004 | High-density lipoproteins neutralize C-reactive protein proinflammatory activity | Wadham, C.; Albanese, N.; Roberts, J.; Wang, L.; Bagley, C.; Gamble, J.; Rye, K.; Barter, P.; Vadas, M.; Xia, P. |
| 2000 | Human sphingosine kinase: purification, molecular cloning and characterization of the native and recombinant enzymes | Pitson, S.; D'Andrea, R.; Vandeleur, L.; Moretti, P.; Xia, P.; Gamble, J.; Vadas, M.; Wattenberg, B. |
| 1999 | Hypoxic Regulation of Vascular Endothelial Growth Factor mRNA Stability Requires the Cooperation of Multiple RNA Elements | Dibbens, J.; Miller, D.; Damert, A.; Risau, W.; Vadas, M.; Goodall, G.; Massague, J. |
| 1995 | Interferon gamma upregulates IL-3 receptor expression in human endothelial cells and synergises with IL-3 in stimulating MHC class II expression and cytokine production | Korpelainen, E.; Gamble, J.; Smith, W.; Dottore, M.; Vadas, M.; Lopez, A. |
| 2009 | JAM-C Induces endothelial cell permeability through its association and regulation of beta(3) integrins | Li, X.; Stankovic, M.; Lee, B.; Aurrand-Lions, M.; Hahn, C.; Lu, Y.; Imhof, B.; Vadas, M.; Gamble, J. |
| 2001 | Lack of effect of serum amyloid A (SAA) on the ability of high-density lipoproteins to inhibit endothelial cell adhesion molecule expression | Ashby, D.; Gamble, J.; Vadas, M.; Fidge, N.; Siggins, S.; Rye, K.; Barter, P. |
| 1999 | Letter to the Editor: 1H and 15N chemical shift assignments for domain 4 of the common β-chain of the IL-3, IL-5 and GM-CSF receptors | Mulhern, T.; Bagley, C.; Gaunt, C.; Lopez, A.; Vadas, M.; D'Andrea, R.; Booker, G. |
| 1996 | Monoclonal antibody 7G3 recognises the N-terminal domain of the human IL-3 receptor and functions as a specific IL-3 receptor antagonist | Qiyu, S.; Woodcock, J.; Stomski, F.; Bagley, C.; Goodall, G.; Smith, W.; Vadas, M.; Lopez, A. |
| 1995 | Neutrophils activated by granulocyte-macrophage colony-stimulating factor express receptors for interleukin-3 which mediate class II expression | Smith, W.; Guida, L.; Qiuy, S.; Korpelainen, E.; van den Hueven, C.; Gillis, D.; Hawrylowicz, C.; Vadas, M.; Lopez, A. |
| 1997 | New frontiers for IL-5 | Bagley, C.; Lopez, A.; Vadas, M. |
| 2003 | New therapeutic targets in vascular biology | Imhof, B.; Vadas, M. |
| 2001 | Nucleotide sequence of the mouse VEGF 3'UTR and quantitative analysis of sites of polyadenylation | Dibbens, J.; Polyak, S.; Damert, A.; Risau, W.; Vadas, M.; Goodall, G. |
| 2001 | Peptide insertions in domain 4 of hbc, the shared signalling receptor subunit for GM-CSF, IL3 and IL5, induce ligand-independent activation | Jones, K.; Bagley, C.; Butcher, C.; Barry, S.; Vadas, M.; D'Andrea, R. |
| 2006 | Phenoxodiol, an experimental anticancer drug, shows potent antiangiogenic properties in addition to its antitumour effects | Gamble, J.; Xia, P.; Hahn, C.; Drew, J.; Drogemuller, C.; Brown, D.; Vadas, M. |
| 2000 | Phospholipid composition of reconstituted high density lipoproteins influences their ability to inhibit endothelial cell adhesion molecule expression | Baker, P.; Rye, K.A.; Gamble, J.; Vadas, M.; Barter, P. |